GlassScriptPhysician profile
Emily Jordan
NPI 1164112389
$925.61
in general payments reported to CMS, 2019-2025
17 companies · $29.60 in 2025
The $29.60 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $230 · 2024: $666 · 2025: $29.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $926.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $925.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals International, Plc | $124.45 | 2024 | Arcalyst |
| Boehringer Ingelheim Pharmaceuticals, INC. | $121.72 | 2023-2024 | Jardiance |
| Janssen Pharmaceuticals, INC | $97.29 | 2023-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $71.42 | 2023-2024 | |
| Merck Sharp & Dohme LLC | $67.55 | 2023 | Verquvo |
| E.R. Squibb & Sons, L.L.C. | $66.60 | 2024 | Camzyos |
| Novo Nordisk INC | $64.66 | 2024 | Wegovy, Ozempic |
| Pfizer INC. | $50.17 | 2024 | |
| Lexicon Pharmaceuticals, INC. | $50.10 | 2023 | Inpefa |
| Amgen INC. | $48.07 | 2024 | Repatha |
| Kiniksa Pharmaceuticals, LTD. | $35.56 | 2023 | Arcalyst |
| Abbott Laboratories | $29.60 | 2025 | Amplatzer Amulet |
| Biotronik INC. | $23.38 | 2024 | Biomonitor, Amvia Edge |
| Medtronic, INC. | $20.79 | 2024 | Tyrx |
| Esperion Therapeutics, INC. | $20.38 | 2024 | Nexletol |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $17.90 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Astrazeneca Pharmaceuticals LP | $15.97 | 2024 | Farxiga |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Jordan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.